Inspire Medical Systems (INSP) Stock: Buy, Sell, or Hold?

INSP - Inspire Medical Systems, Inc.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$70.78
1.42 (2.05%) ▲
5d: +2.86%
30d: +15.05%
90d: +50.76%
WAIT
LOW Confidence
Protect Your INSP Gains
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 02, 2026 30d

Get Alerted When INSP Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: INSP is fairly priced but lacks strong directional signals. At 6.7% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$72.49
Based on 13.7% avg growth
INTRINSIC VALUE TODAY
$45.01
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: INSP is currently trading at $70.78, which is considered slightly high relative to its 30-day fair value range of $62.62 to $73.03. From a valuation perspective, the stock is trading at a premium (Forward PE: 46.0) compared to its historical average (37.9). At these levels, the market is pricing in 6.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, INSP is in a strong uptrend. Immediate support is located at $68.13, while resistance sits at $78.80.

Market Sentiment: INSP scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $62.80. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $62.62 - $73.03
Company Quality Score 45/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 33.3%

Protect Your Profits

Holding INSP? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Weak technical setup (32/100)
  • BULLISH: High volume confirmation
  • BEARISH: Trading 11.3% above Wall St target ($62.80)
  • NEUTRAL: PE elevated vs history but 6.7% growth expectation is conservative given 308% recent growth
  • WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $62.62 - $73.03
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $68.13
Resistance Level $78.80
Current Trend Strong Uptrend
Technical data as of Oct 1, 2026

Fundamental Context

Forward P/E (Next Year Est.) 45.96
Wall Street Target $62.80 (-11.3%)
Revenue Growth (YoY) -7.6%
Earnings Growth (YoY) 308.4%
Profit Margin 15.0%
Valuation Premium vs History +6.7% premium
PE vs Historical 46.0 vs 37.9 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +6.7% (market-implied from PE analysis)
1-Year Target $75.52 (+7%)
2-Year Target $80.58 (+14%)
3-Year Target $85.98 (+22%)
3-Yr Target (if PE normalizes) (PE: 46→38) PE COMPRESSION $70.90 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 46.0, Growth: 23.4%) $133.13 (+88%)
Base: (SPY PE: 20.4, Growth: 23.4%) $59.09 (-17%)
Bear: (PE: 17.3, Growth: 23.4%) $50.22 (-29%)
📈 Valuation based on Current Earnings
Trailing PE: 15.31 | Current EPS (TTM): $4.53
Bull Case $38.15 (-46%)
Analyst growth -50.0%, PE expands to 16.8
Base Case $34.68 (-51%)
Market implied -50.0%, PE stable at 15.3
Bear Case $47.16 (-33%)
Severe decline -20.0%, PE contracts to 13.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 02, 2026 12:48 AM ET
Data refreshes hourly during market hours. Next update: 1:48 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for INSP.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SYK
Stryker Corporation
BUY
32 analysts
$369 64 BUY
DXCM
DexCom Inc
STRONG BUY
27 analysts
$94 48 HOLD
ABT
Abbott Laboratories
STRONG BUY
27 analysts
$120 49 HOLD
EW
Edwards Lifesciences Corp
HOLD
32 analysts
$101 57 HOLD
GEHC
GE HealthCare Technologiâ€Ļ
STRONG BUY
21 analysts
$83 56 HOLD

Advanced INSP Option Strategies

Professional options setups generated by AI based on today's INSP price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for INSP

INSP Technical Chart INSP Price Prediction INSP Earnings Date Why is INSP Moving Today? INSP Investment Advisor INSP Fair Price Analyzer INSP Options Advisor INSP Options Chain INSP Options Analysis INSP Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals